United Kingdom

Fuji Pharma Co Ltd (4554.T)

4554.T on Tokyo Stock Exchange

23 Aug 2019
Change (% chg)

¥-26 (-1.99%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Hirofumi Imai

51 2016 Chairman of the Board, Representative Director

Eiji Takemasa

57 2016 President, Representative Director

Takayuki Kasai

2016 Vice President, Chief Director of Production, Director

Satoru Hiromi

60 2010 Managing Director, Executive Officer, Toyama Plant Manager, Director of Quality Management

Atsuya Mitsuhashi

45 2016 Managing Executive Officer, Chief Director of Sales